OmnySense

Digital health company with a proprietary personal health-assessment solution.

Health Tech & Life Sciences
Active
Seed Tel Aviv-Yafo Founded 2019
Total raised
$1.5M
Last: Seed 2022-02
Stage
Seed
Founded
2019
Headcount
8
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

OmnySense helps people make informed health decisions at home, when they feel unwell or uncertain. Our smart multi-sensor device and AI-powered app measure and interpret key clinical parameters as simply as using a thermometer. Providing a clear medical assessment that helps people decide when to act and what to do next.

Each measurement contributes to a unique and continuously evolving layer of Real-World Physiological Data - structured, contextual, and clinically meaningful. Creating value for individuals, healthcare systems, and the wider health industry.

Funding history · 2 rounds · $1.5M total

2022-02
Seed $1.5M
2022-01
Crowdfunding Undisclosed

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was OmnySense founded and where is its headquarters located?
OmnySense was founded in May 2019 and is headquartered in Tel Aviv-Yafo, Israel.
What is OmnySense's primary focus in the digital health sector?
OmnySense focuses on providing a proprietary personal health-assessment solution through a smart multi-sensor device and an AI-powered app that measures and interprets key clinical parameters for informed health decisions at home.
What was OmnySense's most recent funding round?
OmnySense completed a Seed funding round in February 2022, raising $1,500,000 from undisclosed investors. This followed a Crowdfunding round in January 2022 with ExitValley.
How many employees does OmnySense currently have?
OmnySense currently has 8 employees.
What patent was OmnySense awarded in November 2024?
In November 2024, OmnySense was awarded a US patent for a smart-thermometer with an integrated 3/6-lead ECG.
What is OmnySense's initial patient focus for its health assessment solution, as announced in March 2025?
In March 2025, OmnySense announced its intention to target oncology patients as the initial focus for its personal health-assessment solution.
What technology is OmnySense leveraging to deliver immediate medical assessments at home, according to a September 2024 report?
According to a September 2024 report, OmnySense is leveraging Med LMs (Medical Large Models) to deliver immediate medical assessments at home.
What was confirmed by a study in August 2024 regarding OmnySense's method?
In August 2024, a study confirmed OmnySense’s innovative and practical method for performing respiratory assessment at home.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical MonitorsDigital HealthcarePatient Remote Monitoring
Technologies
Data StorageCloudSensingPlatforms & InterfacesCommunications
Target customers
ConsumersDemographics & FamilySeniorsChildrenHealthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B2CB2CB2B

Highlights

1 PatentsVerified

Tags

digital-healthcarehome-carealert-systemtelehealthtelemedicinecloud-basedseniorsdoctorsremote-monitoringclinicspatientsmedical-devices